Compare Herbalife Nutrition Ltd (HLF) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Herbalife Nutrition Ltd vs BIO-TECHNE Corp — how do they compare? Herbalife Nutrition Ltd trades at $11.76 (market cap $1.21B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 9.3× Herbalife Nutrition Ltd's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| HLF | TECH | |
|---|---|---|
Market Cap | $1.21B | $11.24B |
Sector | Consumer Staples | Health |
52-Week High | $19.96 | $72.29 |
52-Week Low | $7.75 | $43.31 |
Enterprise Value | $3.04B | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HLF trades at $12.35, up 7.3% today, amid a bearish technical signal but supported by strong analyst consensus. The stock shows attractive valuation with a P/E of 7.92 and P/S of 0.25, while recent Q2 2026 earnings missed estimates but revenue grew 5.4% year-over-year. The company has achieved four consecutive quarters of sales growth and was recently named to TIME's list of America's Best Companies 2026.
The outlook is mixed: low valuations and sales growth offer upside, but negative shareholder equity, high debt, and earnings volatility pose risks. Wall Street sentiment is bullish with 54% buy ratings, yet technical indicators suggest near-term pressure. Investors should weigh fundamental strength against financial leverage and market sentiment shifts.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Herbalife Nutrition Ltd
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
